Lv1
40 积分 2024-10-12 加入
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
12小时前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
1天前
已完结
急性B淋巴细胞白血病嵌合抗原受体-T细胞免疫治疗后血清细胞因子水平与桥接异基因造血干细胞移植预后的相关研究
4个月前
已完结
B细胞靶向药物治疗风湿免疫病中国专家共识（2024版）
7个月前
已完结
JAK inhibition for CD3− CD4+ lymphocytic-variant hypereosinophilic syndrome
7个月前
已完结
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations
8个月前
已完结
Epstein-Barr virus as a potentiator of autoimmune diseases
1年前
已完结
皖公网安备34019202002308
